Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-Angle Glaucoma or Ocular Hypertension

Completed · Phase 3 · Has a placebo group

Conditions studied: Glaucoma, Open-Angle, Ocular Hypertension

In brief

This study will evaluate the efficacy and safety of bimatoprost sustained-release (SR) in patients with open-angle glaucoma or ocular hypertension. The study includes a 12-month treatment period with an 8-month extended follow-up.

Key facts

Study ID
NCT02250651
Run by
Allergan
People needed
528
Starts
2014-12-15
Expected to finish
2020-07-22
Last updated by the study team
2021-07-28

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.